TWI290141B - N-(heterocyclyl)benzene-or-pyridinesulphonamides derivatives, their preparation and their therapeutic application - Google Patents

N-(heterocyclyl)benzene-or-pyridinesulphonamides derivatives, their preparation and their therapeutic application Download PDF

Info

Publication number
TWI290141B
TWI290141B TW090106733A TW90106733A TWI290141B TW I290141 B TWI290141 B TW I290141B TW 090106733 A TW090106733 A TW 090106733A TW 90106733 A TW90106733 A TW 90106733A TW I290141 B TWI290141 B TW I290141B
Authority
TW
Taiwan
Prior art keywords
group
amino
alkyl
compound
butyl
Prior art date
Application number
TW090106733A
Other languages
English (en)
Chinese (zh)
Inventor
Jean-Michel Altenburger
Gerard Cremer
Gilbert Lassalle
Mostafa Matrougui
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of TWI290141B publication Critical patent/TWI290141B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
TW090106733A 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-or-pyridinesulphonamides derivatives, their preparation and their therapeutic application TWI290141B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
TWI290141B true TWI290141B (en) 2007-11-21

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
TW090106733A TWI290141B (en) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-or-pyridinesulphonamides derivatives, their preparation and their therapeutic application

Country Status (34)

Country Link
US (1) US6680329B2 (enExample)
EP (1) EP1268469B1 (enExample)
JP (1) JP2003528098A (enExample)
KR (1) KR100791693B1 (enExample)
CN (1) CN1183128C (enExample)
AR (1) AR029900A1 (enExample)
AT (1) ATE269325T1 (enExample)
AU (2) AU2001246617B2 (enExample)
BG (1) BG65863B1 (enExample)
BR (1) BR0109385A (enExample)
CA (1) CA2401637C (enExample)
DE (1) DE60103868T2 (enExample)
DK (1) DK1268469T3 (enExample)
EA (1) EA004986B1 (enExample)
EE (1) EE05084B1 (enExample)
ES (1) ES2222358T3 (enExample)
FR (1) FR2806722B1 (enExample)
HR (1) HRP20020762B1 (enExample)
HU (1) HUP0300695A2 (enExample)
IL (2) IL151619A0 (enExample)
IS (1) IS2304B (enExample)
ME (1) MEP17408A (enExample)
MX (1) MXPA02009276A (enExample)
NO (1) NO324835B1 (enExample)
PL (1) PL204660B1 (enExample)
PT (1) PT1268469E (enExample)
RS (1) RS50370B (enExample)
SI (1) SI1268469T1 (enExample)
SK (1) SK286687B6 (enExample)
TR (1) TR200402343T4 (enExample)
TW (1) TWI290141B (enExample)
UA (1) UA71667C2 (enExample)
WO (1) WO2001070736A1 (enExample)
ZA (1) ZA200206996B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508165C (en) 2002-12-06 2014-05-06 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
WO2005102991A1 (ja) * 2004-04-19 2005-11-03 Daiso Co., Ltd. 非天然型アミノ酸の製造方法およびその中間体
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
JP2011522801A (ja) * 2008-05-22 2011-08-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング CCR10のα−置換N−スルホニルグリシン(GYLCINE)アミドアンタゴニスト、それらを含有する組成物およびそれらを使用するための方法
WO2011094496A2 (en) * 2010-01-28 2011-08-04 The Medicines Company Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
ZA200206996B (en) 2003-09-01
IL151619A (en) 2009-05-04
SK286687B6 (sk) 2009-03-05
YU67002A (sh) 2005-07-19
HRP20020762A2 (en) 2003-12-31
AU4661701A (en) 2001-10-03
TR200402343T4 (tr) 2004-12-21
CN1183128C (zh) 2005-01-05
PL364988A1 (en) 2004-12-27
HK1051537A1 (en) 2003-08-08
DK1268469T3 (da) 2004-10-11
BR0109385A (pt) 2003-06-03
UA71667C2 (uk) 2004-12-15
ATE269325T1 (de) 2004-07-15
FR2806722B1 (fr) 2002-05-17
KR20020081476A (ko) 2002-10-26
PL204660B1 (pl) 2010-01-29
IL151619A0 (en) 2003-04-10
EP1268469B1 (fr) 2004-06-16
IS2304B (is) 2007-10-15
EA004986B1 (ru) 2004-10-28
CA2401637C (en) 2009-11-10
WO2001070736A1 (fr) 2001-09-27
CN1426407A (zh) 2003-06-25
FR2806722A1 (fr) 2001-09-28
BG107130A (bg) 2003-06-30
NO20024496D0 (no) 2002-09-19
SK13512002A3 (sk) 2003-03-04
AU2001246617B2 (en) 2006-03-02
NO324835B1 (no) 2007-12-17
EA200200838A1 (ru) 2003-04-24
MXPA02009276A (es) 2003-05-23
RS50370B (sr) 2009-11-10
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
EP1268469A1 (fr) 2003-01-02
MEP17408A (en) 2010-06-10
ES2222358T3 (es) 2005-02-01
AR029900A1 (es) 2003-07-23
IS6535A (is) 2002-08-30
BG65863B1 (bg) 2010-03-31
HRP20020762B1 (en) 2005-02-28
EE200200540A (et) 2004-04-15
NO20024496L (no) 2002-11-22
JP2003528098A (ja) 2003-09-24
KR100791693B1 (ko) 2008-01-03
US20030207920A1 (en) 2003-11-06
SI1268469T1 (en) 2004-10-31
US6680329B2 (en) 2004-01-20
HUP0300695A2 (hu) 2003-07-28
PT1268469E (pt) 2004-10-29
EE05084B1 (et) 2008-10-15
CA2401637A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
TWI292399B (en) Pharmaceutical compositions and combinations of novel non-imidazole compounds
AU2004281216B2 (en) Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
JP4025200B2 (ja) ピペリジンmchアンタゴニストおよび肥満の処置におけるそれらの使用
US20090197859A1 (en) Pyridinyl Amides for the Treatment of CNS and Metabolic Disorders
TWI364420B (en) Novel piperazine amide derivatives
JP2014166961A (ja) 新規インダゾール誘導体
TW201035102A (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
TW200815431A (en) Azabenzimidazolyl compounds
CN1960727B (zh) 用作组胺-3受体的配体的萘衍生物
TW394771B (en) Novel substituted 4-(lh-benzimidazol-2-yl-amino)-piperidines useful for the treatment of allergic diseases
JPH08504786A (ja) 5−ht▲下1▼様アゴニスト用トリプタミンアナログ
TW200940523A (en) Substituted sulfonamide derivatives
ES2233302T3 (es) Derivados de piridina o de piperidina para el tratamiento de enfermedades neurodegenerativas.
IL151619A (en) N - (Tirocyclil) Gasoline or pyridine sulfonamides, processes for their preparation in their pharmaceutical preparations
JPWO2003020703A1 (ja) 環状アミン化合物
TW200808764A (en) Cyclic amine compound
MX2007016541A (es) Compuestos quimicos.
TWI334413B (en) New benzoyl piperidine compounds
Russo et al. A two-step synthesis of aminopropylpiperidines via aminopropargylpyridines, suitable for the synthesis of a new class of 5-HT4 ligands
KR20070034066A (ko) 4-아릴모르폴린-3-온 유도체, 그의 제법 및 치료적 용도
Kovalskiy et al. Synthesis of 3-(3-piperidyl)-isoquinoline and 3-(4-piperidyl)-isoquinoline
WO2003049737A1 (en) Chemical compounds